Europe Gamma Knife Market

Europe Gamma Knife Market Size (2024 to 2029)

As per the research report, the size of the Europe Gamma Knife Market is valued at USD 61.43 million in 2024 and estimated to be growing at a CAGR of 8.46%, to reach USD 92.20 million by 2029 during the forecast period 2024 to 2029.

The growing prevalence of brain tumors and cancer, combined with the increasing use of gamma knives, drives the European gamma knife market.

According to World Health Organisation data, cancer is one of the leading causes of mortality worldwide, with an estimated 9.6 million people dying from it in 2018. Therefore, the rising occurrence of cancer and brain tumors is driving the gamma knife industry in Europe. Furthermore, due to the growing patient population of the central nervous system and brain tumors across Europe, several medical device makers are focusing on creating gamma knife tools.

The use of gamma knife radiosurgery in treating brain tumors, epilepsy, neurological diseases, malformations, and other central nervous system problems is increasing, which is expected to enhance the Europe gamma knife market growth significantly. 

The increased prevalence of cancer, obesity, an aging population, and an increasing number of persons suffering from brain metastases, neuralgia, and other disorders contribute to the market's expansion. Furthermore, the growing use of gamma knife equipment in cancer surgical centers boosts the European gamma knife market's growth rate.

These factors mentioned above are predicted to drive the Europe Gamma Knife market during the forecast period.

The most significant limitation to expanding the Europe gamma knife market is the side effects and high prices associated with gamma knife instruments. The gamma knife business is further hampered by rigorous restrictions and a scarcity of competent professionals in the healthcare industry. The market is further constrained by a lack of healthcare infrastructure in developing countries.

The drawbacks of Gamma knife radiosurgery, on the other hand, also include the inability to manage large lesions or malignant tumors, a relatively slow treatment impact, the risk of radiation harm to the optic nerve, and a treatment range limit.

This research report on the Europe Gamma Knife Market has been segmented and sub-segmented into the following categories.

Europe Gamma Knife Market Analysis By Disease Indication

• Brain Metastasis
• Cancer
• Trigeminal Neuralgia
• AVM
• Others

Europe Gamma Knife Market Analysis By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European Gamma Knife market is the third-largest market globally in terms of market share due to the rising cancer prevalence, and an aging population is likely to fuel market expansion.

The increasing prevalence of cancer in Europe increases the demand for Gamma Knives. However, according to the World Health Organization, Europe contains only one-eighth of the world's population.

The U.K Gamma Knife Market is expected to lead the Europe Gamma Knife market because of the rising prevalence of cancer and obesity and the aging population in the United Kingdom; the Gamma Knife industry is booming. Furthermore, the enhanced characteristics of Gamma Knife systems and the growing number of efforts undertaken by government associations are propelling the market forward.

The Germany Gamma Knife Market is estimated to grow significantly due to the increasing deployment of gamma knife systems in hospitals throughout Europe; the gamma knife market is likely to rise significantly. 

Elekta stated in 2017 that the Poliambulanza Foundation Hospital is the world's 50th health center and the first in Italy to use its Leksell Gamma Knife Icon stereotactic radiosurgery (SRS) equipment to treat patients.

KEY MARKET PLAYERS

Key players dominating the Europe Gamma Knife Market profiled in this report are Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., ET Medical Group and American Shared Hospital Services, Masep Infini Europe, Inc., Varian Medical Systems, Hokai, Nordion Inc.,